REVOLUTION MEDICINES INC (RVMD) Stock Balance Sheet
NASDAQ:RVMD • US76155X1000
Current stock price
98.11 USD
-1.02 (-1.03%)
At close:
99.5 USD
+1.39 (+1.42%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 383.75M | 543.06M | 696.15M | 161.40M | 108.50M | |||
| Marketable Securities | 1.64B | 1.75B | 1.16B | 483.50M | 468.60M | |||
| Receivables | N/A | 0.00 | 1.25M | 4.70M | 5.90M | |||
| Other Current Assets | 49.36M | 38.33M | 25.07M | 10.60M | 6.80M | |||
| Total Current Assets | 2.08B | 2.33B | 1.88B | 660.20M | 589.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 165.28M | 141.82M | 100.01M | 73.70M | 71.20M | |||
| Goodwill | 14.61M | 14.61M | 14.61M | 14.60M | 14.60M | |||
| Intangibles | 55.80M | 56.67M | 57.74M | 58.80M | 59.90M | |||
| Other Non-Current Assets | 43.78M | 17.57M | 10.06M | 4.60M | 2.50M | |||
| Total Non-Current Assets | 279.47M | 230.67M | 182.42M | 151.70M | 148.20M | |||
| TOTAL ASSETS | 2.35B | 2.56B | 2.06B | 811.90M | 738.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 217.95M | 108.90M | 78.17M | 35.70M | 33.60M | |||
| Accounts Payable | 64.62M | 54.43M | 61.79M | 21.30M | 14.10M | |||
| Other Current Liabilities | 7.86M | 583.00K | 3.90M | 5.00M | 12.70M | |||
| Total Current Liabilities | 290.42M | 163.91M | 143.85M | 62.00M | 60.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 268.45M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 2.35M | 2.35M | 3.12M | 7.00M | 7.40M | |||
| Other Non-Current Liabilities | 161.99M | 126.83M | 88.55M | 57.70M | 67.60M | |||
| Total Non-Current Liabilities | 432.79M | 129.18M | 91.66M | 64.70M | 75.00M | |||
| TOTAL LIABILITIES | 723.21M | 293.10M | 235.51M | 126.70M | 135.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.87B | -1.74B | -1.14B | -701.30M | -452.60M | |||
| Additional Paid In Capital | 4.50B | 4.00B | 2.96B | 1.39B | 1.06B | |||
| Common Shares | 19.00K | 18.00K | 16.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 197.00M | 185.90M | 164.67M | 90.50M | 74.10M | |||
| Tangible Book Value per Share | 7.92 | 11.80 | 10.65 | 6.76 | 7.13 | |||
| Total Shareholders' Equity | 1.63B | 2.27B | 1.83B | 685.20M | 602.60M | |||
| TOTAL LIABILITIES AND EQUITY | 2.35B | 2.56B | 2.06B | 811.90M | 738.00M | |||
| Statistics | ||||||||
| Debt/Equity | 0.16 | N/A | N/A | N/A | N/A | |||
| Current Ratio | 7.14 | 14.20 | 13.06 | 10.65 | 9.76 | |||
| Return On Assets (ROA) | -48.05% | -23.46% | -21.17% | -30.63% | -25.35% | |||
| Return On Equity (ROE) | -69.35% | -26.49% | -23.89% | -36.30% | -31.05% | |||
All data in USD , ROIC based on taxRate of 0.21